United States
  • Europe
    • FR
    • DE
    • IT
    • ES
    • NL
    • PL
    • UK
  • News
  • US
  • World
  • Business
  • Technology
  • Science
  • Entertainment
  • Sports
  • Health
  • Africa

Categories

  • Artificial intelligence
  • Arts and design
  • Books
  • Business
  • Celebrities
  • Chicago
  • Computing
  • Dallas
  • Economy
  • Entertainment
  • Entrepreneurship
  • Environment
  • Fitness
  • Fort Worth
  • Gadgets
  • Genetics
  • Golf
  • Health
  • Health care
  • Houston
  • Internet
  • Jacksonville
  • Jobs
  • Los Angeles
  • Markets
  • Medication
  • Mental health
  • MLB
  • Mobile
  • Movies
  • Music
  • NASCAR
  • NBA
  • NCAA Basketball
  • NCAA Football
  • New York
  • News
  • NFL
  • NHL
  • Nutrition
  • Personal finance
  • Philadelphia
  • Phoenix
  • Physics
  • San Antonio
  • San Diego
  • Science
  • Soccer
  • Space
  • Sports
  • Technology
  • Tennis
  • TV
  • United States
  • US
  • Virtual reality
  • Wildlife
  • WNBA
  • World
United States
  • Europe
    • FR
    • DE
    • IT
    • ES
    • NL
    • PL
    • UK
  • News
  • US
  • World
  • Business
  • Technology
  • Science
  • Entertainment
  • Sports
  • Health
  • Africa

Browsing Tag

estimate revisions

2 posts
MMedication
All You Need to Know About Milestone Pharmaceuticals (MIST) Rating Upgrade to Strong Buy
Read More

All You Need to Know About Milestone Pharmaceuticals (MIST) Rating Upgrade to Strong Buy

  • January 28, 2026
Milestone Pharmaceuticals (MIST) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1…
GGenetics
Opus Genetics, Inc. (IRD) Reports Q2 Loss, Lags Revenue Estimates
Read More

Opus Genetics, Inc. (IRD) Reports Q2 Loss, Lags Revenue Estimates

  • August 13, 2025
Opus Genetics, Inc. (IRD) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus…
United States
www.europesays.com